Increased conviction in Fidelity Small Cap Growth’s approach merits upgrading its Process rating to High from Above Average; the strategy’s People rating remains Above Average.
Fidelity Advisor Small Cap Growth Fund - Class A FCAGX
- NAV / 1-Day Return 30.87 / +1.35 %
- Total Assets 8.9B
-
Adj. Expense Ratio
1.160%
- Expense Ratio 1.160%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 0
- Status Limited
- TTM Yield 0.00
- Turnover 97%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis FCAGX
Will FCAGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 10.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Fidelity Cash Central Fund | 1.70 | 149M | Cash and Equivalents |
BrightSpring Health Services Inc | 1.36 | 119M | Healthcare |
Enova International Inc | 1.15 | 102M | Financial Services |
Cogent Biosciences Inc | 1.11 | 98M | Healthcare |
InterDigital Inc | 1.03 | 90M | Technology |
Intapp Inc | 1.01 | 89M | Technology |
Enliven Therapeutics Inc | 0.95 | 83M | Healthcare |
Rush Street Interactive Inc Ordinary Shares - Class A | 0.87 | 77M | Consumer Cyclical |
Spyre Therapeutics Inc | 0.87 | 76M | Healthcare |
Xometry Inc Ordinary Shares - Class A | 0.84 | 74M | Industrials |